Biotech News

UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

Pennant Group (PNTG)Pennant Group2026-03-17 17:40 ESTConference / presentation

EAGLE, Idaho, March 17, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Oppenheimer Co.

Open original release

Related news

PNTGPennant Group2026-06-04 15:16 EST

The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut

PNTGPennant Group2026-06-03 11:00 EST

Pennant Expands Senior Living Presence with Pleasant Hill, California Community

PNTGPennant Group2026-05-18 22:03 EST

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference

PNTGPennant Group2026-05-18 21:22 EST

Pennant Announces an Acquisition of Senior Living Community in Arizona

PNTGPennant Group2026-05-06 20:05 EST

Pennant Reports First Quarter 2026 Results

PNTGPennant Group2026-05-04 23:34 EST

Pennant Announces First Quarter 2026 Earnings Release and Call

PNTGPennant Group2026-05-01 22:28 EST

Pennant Acquires Senior Living Communities in Arizona and Wisconsin

PNTGPennant Group2026-04-01 20:53 EST

Pennant Acquires Arbor Rose Senior Living Community in Mesa, Arizona

PNTGPennant Group2026-03-16 22:15 EST

Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

PNTGPennant Group2026-02-25 21:25 EST

Pennant Reports Fourth Quarter and Fiscal Year 2025 Results

View all latest news

Pennant Group

The Pennant Group is a healthcare services company focused on home health, hospice, and senior-care operations. Its business is centered on post-acute care delivery rather than biotech or devices.

Recent company news

PNTGBruker2026-07-24 20:01 EST

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

PNTGQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

PNTGMolina Healthcare2026-07-22 20:15 EST

Molina Healthcare Reports Second Quarter 2026 Financial Results

PNTGAxon Enterprise, Inc.2026-07-22 20:01 EST

Axon to Release Second Quarter 2026 Earnings on August 5, 2026

PNTGGSK plc2026-07-22 11:21 EST

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Stock data

Close: 39.81 USD
Market cap: 1.07B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States